Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET™

Bibliography

• QUATTRIN T: Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes. Expert Opin. Pharmacother. (2004) 5(12):2597-2604.
   PubMed Web of Science ®Google Scholar
• AMIDON G, LENNERNAS H, SHAH VP, CRISON J: A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. (1995) 12(3):413-420.
   PubMed Web of Science ®Google Scholar
• TENJARLA S: Microemulsions: an overview and pharmaceutical applications. Crit. Rev. Ther. Drug Carrier Syst. (1999) 16(5):461-521.
   PubMed Web of Science ®Google Scholar
• THANOU M, VERHOEF JC, JUNGINGER H: Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. (2001) 52(2):117-126.
   PubMed Web of Science ®Google Scholar
• KIDRON M, DINH S, MENACHEM Y et al.: A novel per-oral insulin formulation: proof-of-concept study in non-diabetic subjects. Diabet. Med. (2004) 21:354-357.
   Google Scholar
• POZZILLI P, MANFRILI S, COSTANZA F et al.: Biokinetics of buccal spray insulin in patients with Type 1 diabetes. Metabolism (2005) 54(7):930-934.
   PubMed Web of Science ®Google Scholar
• CHIN CM, GUTIERREZ M, STILL JG, KOSUTIC G: Pharmacokinetics of modified oral calcitonin product in healthy volunteers. Pharmacotherapy (2004) 24(8):994-1001.
   PubMed Web of Science ®Google Scholar
• SANTOS CA, FREEDMAN BD, GHOSN S, JACOB JS, SCARPULLA M, MATHIOWITZ E: Evaluation of anhydride oligomers within polymer microsphere blends and their impact on bioadhesion and drug delivery in vitro. Biomaterials (2003) 24(20):3571-3583.
   PubMed Web of Science ®Google Scholar
• BERNKOP-SCHNURCH A: Thiomers: a new generation of mucoadhesive polymers. Adv. Drug Deliv. Rev. (2005) 57(11):1569-1582.
   PubMed Web of Science ®Google Scholar
• SALAMA NN, FASANO A, THAKAR M, EDDINGTON ND. The impact of ΔG on the oral bioavailability of low bioavailable therapeutic agents. J. Pharm. Exp. Ther. (2005) 312:199-215.
   PubMed Web of Science ®Google Scholar
• LEE YH, LEESMAN JD, MAKHEY V et al.: Regional oral absorption, hepatic first-pass effect, and non-linear disposition of salmon calcitonin in beagle dogs. Eur. J. Pharm. Biopharm. (2000) 50(2):205-211.
   PubMed Web of Science ®Google Scholar
• KALARLI TT: Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. (1995) 16(5):351-380.
   PubMed Web of Science ®Google Scholar
• SAWADA T, OGAWA T, TOMITA M, HAYASHI, M, AWAZU S: Role of paracellular pathway in non-electrolyte permeation across rat colon epithelium enhanced by sodium caprate and sodium caprylate. Pharm. Res. (1991) 8(11):1365-1371.
   PubMed Web of Science ®Google Scholar
• ANDERBERG EK, LINDMARK T, ARTURSSON P: Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm. Res. (1993) 10(6):857-864.
   PubMed Web of Science ®Google Scholar
• LINDMARK T, NIKKILA T, ARTURSSON P: Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. (1995) 275(2):958-964.
   Google Scholar
• LINDMARK T, SODERHOLM JD, OLAISON G, ALVAN G, OCKLIND G, ARTURSSON P: Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate. Pharm. Res. (1997) 14(7):930-935.
   PubMed Web of Science ®Google Scholar
• SALAMAT-MILLER N, JOHNSTONE TP: Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. Int. J. Pharm. (2005) 294(1-2):201-216.
   PubMedGoogle Scholar
• SODERHOLM JD, OMAN H, BLOMQUIST L, VEEN J, LINDMARK T, OLAISIN G: Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in vitro by sodium caprate, a constituent of milk fat. Dig. Dis. Sci. (1998) 43(7):1547-1552.
   PubMed Web of Science ®Google Scholar
• CRAMER JA, AMONKAR MM, MAYUR M, HEBBORN A, ALTMAN R: Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr. Med. Res. Opin. (2005) 21(9):1453-1460.
   PubMed Web of Science ®Google Scholar
• GORDON DH: Efficacy and safety of intravenous bisphosphonates for patients with breast cancer metastatic to bone: a review of randomized, double-blind, Phase III trials. Clin. Breast Cancer (2005) 6(2):125-131.
   PubMedGoogle Scholar
• MERLI G: Anticoagulants in the treatment of deep vein thrombosis. Am. J. Med. (2005) 118(Suppl. 8A):13S-20S.
   PubMed Web of Science ®Google Scholar
• VAVRA I, MACHOVA A, HOLECEK V, CORT JH, ZAORAL M, SORM F: Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus. Lancet (1968) 1(7549):948-952.
   PubMed Web of Science ®Google Scholar
• IMAI T, SAKAI M, OHTAKE H, AZUMA H, OTAGIRI M: Absorption enhancing effects of glycyrrhizin induced in the presence of capric acid. Int. J. Pharm. (2005) 294(1-2):11-21.
   PubMedGoogle Scholar
• VERVARCKE S, OLLEVIER F, KINGET R, MICHOEL A: Oral vaccination of African catfish with Vibrio anguillarum O2: effect on antigen uptake and immune response by absorption enhancers in lag time coated pellets. Fish Shellfish Immunol. (2004) 18(2):125-133.
   Web of Science ®Google Scholar
• RAOOF AA, CHIU P, RAMTOOLA Z et al.: Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate. J. Pharm. Sci. (2004) 93(6):1431-1439.
   PubMed Web of Science ®Google Scholar
• RAIMON J, TORMALEHTO S, YRITYS K, JUNGINGER HE, MONKKONEN J: Effects of various absorption enhancers on transport of clodronate through Caco-2 cells. Int. J. Pharm. (2003) 261(1-2):129-136.
   PubMedGoogle Scholar
• PETSCHOW PW, BATEMA RP, FORD LL: Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob. Agents Chemother. (1996) 40(2):302-306.
   PubMed Web of Science ®Google Scholar
• VAN IMMERSEEL F, DE BUCK J, BOYEN F et al.: Medium chain fatty acids decrease colonisation and invasion through hilA suppression shortly after infection of chickens with Salmonella enterica serovar enteridis. Appl. Environ. Microbiol. (2004) 70(6):3582-3587.
   PubMed Web of Science ®Google Scholar
• CHADEGANIPOUR M, HAIMS A: Antifungal activities of pelargonic and capric acid on Microsporium gypsum. Mycoses (2001) 44:109-112.
   PubMed Web of Science ®Google Scholar
• BLOMQUIST L, BARK T, HEDENBORG G, NORMAN A: Evaluation of the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Scand. J. Gastroenterol. (1997) 32(8):805-812.
   PubMed Web of Science ®Google Scholar
• WIDMAIER EP, RAFF H, STRANG KT: In: Vander, Sherman and Luciano’s Human Physiology: The Mechanisms of Body Function (9th edn). McGraw Hill Publisher, NY, USA (2004):570-571.
   Google Scholar
• RIVIERE JE, MARTIN-JIMENEZ T, SUNDLOF SF, CRAIGMILL AL: Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. J. Vet. Pharmacol Ther. (1997) 20(6):453-463.
   PubMed Web of Science ®Google Scholar
• BRAYDEN D, CREED E, O’CONNELL A, LEIPOLD H, AGARWAL R, LEONE-BAY A: Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl) amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers. Pharm. Res. (1997) 14(12):1772-1779.
   PubMed Web of Science ®Google Scholar
• MRSNY RJ: Modification of epithelial tight junction integrity to enhance transmucosal absorption. Crit. Rev. Ther. Drug Carrier Syst. (2005) 22(4):331-418.
   PubMed Web of Science ®Google Scholar